Single dose of escitalopram per study period.

A single dose, open-label, randomised, cross-over bioequivalence study in healthy young men comparing two formulations of escitalopram: the conventional immediate release tablet and the to be marketed orally dispersible tablet

A single dose, open-label, randomised, cross-over bioequivalence study in healthy young men comparing two formulations of escitalopram orally dispersible tablets